Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohammad A. Althubiti"'
Autor:
Mahmoud Zaki El-Readi, Ahmed M. Al-Abd, Mohammad A. Althubiti, Riyad A. Almaimani, Hiba Saeed Al-Amoodi, Mohamed Lotfy Ashour, Michael Wink, Safaa Yehia Eid
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Plant secondary metabolites (SMs) common natural occurrences and the significantly lower toxicities of many SM have led to the approaching development and use of these compounds as effective pharmaceutical agents; especially in cancer therapy. A comb
Externí odkaz:
https://doaj.org/article/3b9db436c096471ab18ffd2330c61cdf
Publikováno v:
Saudi Journal of Medicine and Medical Sciences, Vol 8, Iss 2, Pp 95-104 (2020)
Background: Spleen tyrosine kinase (SYK) is an important enzyme in the proliferation and differentiation of all hematopoietic tissues. Its role as a cancer driver is well documented in liquid tumors; however, cumulative evidence has suggested an oppo
Externí odkaz:
https://doaj.org/article/fe0b85b529c845f88e9df685bc14f167
Autor:
Mohammad A Althubiti
Publikováno v:
Saudi Journal of Medicine and Medical Sciences, Vol 7, Iss 1, Pp 16-21 (2019)
Background: Endometrial carcinoma is a predominant health problem for women worldwide. However, there is a lack of data on genetic mutation frequencies in endometrial cancer patients of different ethnicities and tumor grades. Objective: The objective
Externí odkaz:
https://doaj.org/article/eb32cd59a7d849b08dad0432296fdad9
Autor:
Wesam A. Nasif, Abeer S.E. Ali, Asim A. Khogeer, Mohammed H. Mukhtar, Mohamed M. NourEldein, Ahmed Y. Shebly, Shumukh H. Alqahtani, Yahya A. Alnashri, Ghaidaa E. Khouj, Ziyad I. Gadah, Mohammad A. Althubiti
Publikováno v:
Saudi Medical Journal. 43:177-186
To analyze the impact and distribution of blood groups in different ethnicities and the extent of susceptibility to infection with COVID-19 in Makkah, Saudi Arabia.A retrospective study was performed on 4,609 COVID-19 patients from five ethnic groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf7d480bdeaf49553a84184d1f15f8e
https://doi.org/10.15537/smj.2022.43.2.20210847
https://doi.org/10.15537/smj.2022.43.2.20210847
Autor:
Mohamed E. Abdallah, Mahmoud Zaki El-Readi, Mohammad Ahmad Althubiti, Riyad Adnan Almaimani, Amar Mohamed Ismail, Shakir Idris, Bassem Refaat, Waleed Hassan Almalki, Abdullatif Taha Babakr, Mohammed H. Mukhtar, Ashraf N. Abdalla, Omer Fadul Idris
Publikováno v:
Molecules, Vol 25, Iss 15, p 3355 (2020)
Breast cancer is considered as one of the most aggressive types of cancer. Acquired therapeutic resistance is the major cause of chemotherapy failure in breast cancer patients. To overcome this resistance and to improve the efficacy of treatment, dru
Externí odkaz:
https://doaj.org/article/cbe2329c9a1d4e71a68b69fb10e96140